Pfizer/Pharmacia Clears FTC: Viagra Patent Strategy, HRT Safety Are Factors

Pfizer's patent defense strategy for Viagra is one reason the Federal Trade Commission is requiring the divestiture of Phase II erectile dysfunction disorder agents as a condition of the Pfizer/Pharmacia merger